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Abstract
Opt-out HIV testing is recommended for correctional settings but may occur without inmates’ 
knowledge or against their wishes. Through surveying inmates receiving opt-out testing in a large 
prison system, we estimated the proportion unaware of being tested or not wanting a test, and 
associations (prevalence ratios [PRs]) with inmate characteristics. Of 871 tested, 11.8% were 
unknowingly tested and 10.8% had unwanted tests. Not attending an educational HIV course 
(PR=2.34, 95% CI 1.47–3.74), lower HIV knowledge (PR=0.95, 95% CI 0.91–0.98), and thinking 
testing is not mandatory (PR=9.84, 95% CI 4.93–19.67) were associated with unawareness of 
testing. No prior incarcerations (PR=1.59, 95% CI 1.03–2.46) and not using crack/cocaine recently 
(PR=2.37, 95% CI 1.21–4.64) were associated with unwanted testing. Residence at specific 
facilities was associated with both outcomes. Increased assessment of inmate understanding and 
enhanced implementation are needed to ensure inmates receive full benefits of opt-out testing: 
being informed and tested according to their wishes.
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INTRODUCTION
Incarcerated individuals are disproportionately infected with HIV, with an estimated 1 in 7 
HIV-infected persons passing through the criminal justice system annually (1). Due to the 
high prevalence of HIV among incarcerated individuals, jails and prisons have been 
identified as important venues for HIV screening and treatment (2–5). An additional benefit 
of widespread screening of the general inmate population is that it often identifies those who 
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do not perceive themselves to be at high risk for HIV or identify as engaging in high risk 
behaviors, such as having sex with a partner at risk or using non-injection drugs during sex 
(5). Accordingly, several states have implemented mandatory HIV testing policies. A report 
from the U.S. Bureau of Justice Statistics found that in 2008, 24 states tested all inmates for 
HIV infection at some point during their incarceration (6). However, mandatory HIV testing 
of inmates can be viewed as unethical when it requires testing of individuals who may wish 
to remain untested. Particularly in correctional settings, some individuals may be concerned 
about consequences of testing positive such as loss of privacy, stigmatization, and 
segregation (3, 7). Furthermore, mandatory testing can be viewed as compromising an 
individual’s autonomy and freedom to choose whether or not to be tested for HIV, which 
some contend should not be lost when incarcerated (8, 9).
Opt-out testing policies have been promoted as effective alternatives to mandatory testing as 
a means of reaching the greatest number of inmates while preserving their right to refuse the 
test (2, 10), and have been recommended by the Centers for Disease Control (CDC) as a 
component of the standard prison medical evaluation (11). A 2012 survey of all state 
departments of correction found that 17 reported mandatory testing; 11 provided opt-out 
testing; and 10 had opt-in testing, with the remaining states either not reporting, not testing, 
or using some other practice for testing (12). However, the ethical provision of HIV testing 
in correctional settings may be met with challenges even with the use of opt-out policies. For 
example, Seal and colleagues provide a strong ethical argument that institutional factors 
inherent to the criminal justice system, such as a hierarchical chain of command, may result 
in individuals feeling coerced to get tested for HIV even when it is technically voluntary (3, 
13). Furthermore, the situational pressure of being overwhelmed and having other inmates 
standing in close proximity during processing can diminish prisoners’ sense of autonomy in 
deciding to be tested or not, even in opt-out settings (14).
Our research team recently conducted a study examining inmate awareness of HIV testing in 
the North Carolina (NC) prison system, which offers opt-out HIV testing, and found that 
although 95% of 936 prisoners surveyed were tested for HIV, not all inmates fully 
understood that the HIV testing was optional or knew that they had been tested (15). Over 
half of surveyed NC prison inmates incorrectly perceived that testing was mandatory. 
Moreover, 15% had been tested despite not wanting to be tested, and 16% were not able to 
report correctly whether they had been tested (15). This confusion could be due in part to the 
unclear language of the consent form, which combined voluntary HIV testing verbiage with 
mandatory tuberculosis and syphilis testing procedures (15). These findings suggest that 
potential problems may exist in the implementation of opt-out HIV testing in correctional 
settings.
As there has been little research investigating potential gaps in opt-out policy 
implementation, particularly among incarcerated persons, we conducted an exploratory 
study among those prison entrants who we had previously identified to have suboptimal and 
variable awareness of testing procedures. Specifically, we sought to identify factors 
associated with prisoners: 1) being unaware of having been tested; and 2) not wanting to be 
tested. We conclude with a discussion of the implications of our findings for opt-out testing 
in correctional settings.
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Study Setting and Population
To examine prison inmates’ understanding of prison testing policy, between April 2010 and 
March 2011 we surveyed inmates undergoing processing and medical screening at the NC 
state prison system’s seven intake centers that predominantly house adults. Medical 
screening included the opportunity to be tested for HIV. We approached inmates shortly after 
their entry into prison and initiation of medical screening, which included the opportunity to 
test for HIV. The HIV opt-out testing policy in place at the time included the reading aloud a 
statement of general consent by an intake prison nurse and the opportunity for the inmate to 
sign a general consent form. At three facilities, inmates also attended an HIV education 
class, but sometimes this did not occur until after they had been offered HIV testing. Further 
details about the HIV screening process are reported elsewhere (15).
Potential study participants were randomly selected from a roster of inmates at each of the 
seven adult intake prisons. The distribution of intake prisons among the study population 
was designed to reflect the distribution among all inmates admitted to the prison system 
(15). Inmates were eligible for inclusion in the study if they were: 1) age 18 years or older; 
2) English-speaking; 3) not housed in solitary confinement or disciplinary segregation; 4) 
completed all prison health processing activities; 5) recruited within two weeks after having 
been offered the opportunity to test for HIV; and 6) able to provide informed consent to 
participate. The study protocol was approved by the North Carolina Department of Public 
Safety, the Institutional Review Board of the University of North Carolina at Chapel Hill, 
and the Office for Human Research Protection at the U.S. Department of Health and Human 
Services.
After inmates provided informed consent, they completed the study survey in a private room 
at the prison. To minimize social desirability bias in inmates’ responses, we administered the 
surveys using audio computer-assisted self-interviews (ACASI) with touch screen 
computers, whereby inmates could navigate the survey on their own unless they required 
assistance by a research assistant. The survey contained questions about demographics, 
incarceration and HIV testing history, substance use, mental health, sexual risk behaviors, 
attendance at the HIV course, levels of HIV knowledge and stigma, and experiences with 
and perceptions of HIV testing in the prison.
We assessed inmates’ desire to be tested by asking “During processing, did you want to have 
an HIV test?”, and their perception of being tested by querying “Since you’ve been at this 
processing center, have you been tested for HIV?”; inmates could answer “yes” or “no” to 
each question. We coded our study outcomes by linking these variables via a unique 
identification number with electronic laboratory records indicating whether inmates had 
actually been tested for HIV by the prison during processing. This linkage allowed us to 
examine the concordance between inmate testing (tested or not) with their perception of 
being tested and desire to be tested. As described below, these measures of concordance 
were the basis for our two primary outcomes. All identifiers were removed before analysis.
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Analysis of survey data
In the current study, we excluded inmates who reported an HIV-diagnosis prior to their 
incarceration (n=11) and focused our analyses on inmates who had received an HIV test, due 
to the small proportion of inmates who were not tested (5.4%, n=50). Among this 
population, we estimated the percentage (and 95% Confidence Interval [95%CI]) of survey 
respondents endorsing each survey item. We then assessed factors associated with 
discordance in: 1) an inmate’s stated wishes (i.e., wanted to be tested or not) and 2) inmate’s 
awareness of being tested for HIV (i.e., thought he/she was tested or not).
To assess factors associated with discordance between receiving an HIV test and awareness 
of being tested/desire for a test, we estimated the proportion of respondents tested for HIV 
who were unaware of being tested and the proportion who did not want to be tested, for each 
independent variable of a priori interest. These variables included the following: 1) 
demographics, including race/ethnicity, age, gender, sexual identity, and education; 2) 
history of incarceration, including whether they were ever incarcerated and the total length 
of time they had spent in prison or jail; 3) history of HIV testing prior to this incarceration; 
4) substance use, including binge alcohol use and use of other substances in the three 
months prior to incarceration including marijuana, crack and/or powder cocaine, 
methamphetamines, and heroin; 5) prior sexually transmitted infection (STI) diagnosis; 6) 
history of depression and/or anxiety, based on analyses of national data showing that 
depressive symptoms were associated with discrepancies between planned and actual HIV 
testing (16); 7) sexual risk behaviors, including having unprotected vaginal or anal 
intercourse, trading sex, and/or having multiple partners in the three months prior to 
incarceration; 8) attendance at an educational HIV course during their current incarceration; 
9) level of HIV knowledge, calculated as a sum score of 21 true-false items adapted from the 
Brief HIV Knowledge Questionnaire (17); 10) level of perceived HIV stigma, including their 
level of cognitive distancing, a process whereby individuals consider themselves 
fundamentally different from those with HIV (18) (score of four scale items), and also their 
support for mandatory disclosure of an inmate’s HIV status to correctional officers and to 
other inmates (each indicated on a four-point scale ranging from “agree a lot” to “disagree a 
lot”) (19); and 11) whether they perceived the prison had a mandatory HIV testing policy.
We estimated bivariate associations between the independent variables and each outcome. 
(In ancillary analyses, we examined the statistical power for each of our bivariate contrasts). 
We then separately analyzed variables with a statistically significant bivariate association 
(p<0.05) for each outcome using a multivariate model to estimate their association while 
controlling for other covariates in the model. For the outcome of being unaware of being 
tested, we coded our outcome variables so that the prevalence ratio (PR) estimates greater 
than 1 represented an increase in the relative probability of thinking of oneself as not tested; 
similarly, for unwanted testing we coded our outcome so that PR estimates greater than 1 
represented an increase in the relative probability of receiving an unwanted test.
In estimating PRs, we observed several variables for which the subgroup traditionally 
considered to be the “unexposed” (e.g., non-drug users), and thus designated as the referent, 
was more likely to experience our main outcomes than traditional “exposed” (e.g., drug 
users) groups. (We note that this phenomenon occurs regardless of whether the outcome 
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level of interest is framed positively or negatively (e.g., framed as aware of testing or 
unaware of testing). In response, we selected reference groups, regardless of traditional 
“exposure” status, to ensure that PR estimates were available for those subgroups most 
likely to experience the outcome.
To avoid problems with model convergence that may arise with binomial regression, we 
used the modified Poisson approach with robust standard errors to estimate PRs and 
corresponding 95% CIs for our dichotomous outcomes (20). All analyses were conducted 
using SAS version 9.2 (Cary, North Carolina).
RESULTS
Description of Study Sample
Approximately 24,500 inmates were admitted to the NC prison system during the study 
period. Of 1,785 approached to participate in the study, 56% (1,000/1,785) consented to 
participate, 921/1,000 had non-missing data for both of our main outcomes and reported not 
testing HIV-positive before this incarceration, and 871/921 (95%) were tested for HIV. 
Participants were demographically similar to the general prison population, as described 
elsewhere (15).
Of the participants tested for HIV, most were male (86.6%) and self-identified as black 
(46.8%) or white (43.1%). Nearly 25% were 18–24 years of age, 51% were aged 25–40, and 
25% were aged 41–64. The vast majority of respondents had been previously incarcerated 
(83.1%) and 45% had previously spent at least 1 year in prison (Table 1). Most inmates had 
been previously tested for HIV at some point in their lives (81.5%). More than half (63.8%) 
received the informational HIV education course prior to the time of the survey.
HIV Testing Awareness and Desirability
More than half of participants (55.5%) inaccurately reported that HIV testing in prison was 
mandatory (“all inmates have to be tested for HIV—they do not have a choice”). Among the 
study population, which consisted of inmates tested for HIV upon entering prison, 103 
(11.8%) perceived that they had not been tested, and 94 (10.8%) reported that they had not 
wanted an HIV test performed. Together, a total of 166 (19.1%) reported not wanting a test, 
thinking that they had not been tested, or both (see Figure 1).
Predictors of Being Unaware of Testing
In bivariate analyses, incorrectly reporting that one had not been HIV tested (i.e., inmate 
tested but believes he/she was not tested) was positively associated with being male, residing 
in prison facilities M1 and M5 (compared to F1), having no prior incarcerations, not 
attending the HIV course, thinking testing was not mandatory, and increasing cognitive 
distance score (Table 2). Incorrectly reporting that one had not been HIV tested was 
negatively associated with increasing HIV knowledge score and being aged 25–31 
(compared to 18–24 years).
In the multivariable model, incorrectly reporting that one had not been HIV tested was 
associated with residing at prison facilities M1, M2, or M5 (M1: PR=8.25, 95% CI 2.15–
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31.65; M2: PR= 6.46, 95%CI: 1.62–25.75; M5: PR= 4.88, 95% CI: 1.12–21.34 compared to 
F1), not attending the HIV course (PR= 2.34, 95% CI: 1.47–3.74), perceiving testing as not 
being mandatory (PR=9.84, 95% CI 4.93–19.67), and lower HIV knowledge score 
(PR=0.95, 95%CI: 0.91–0.98) (Table 2).
Predictors of Unwanted Testing
In bivariate analyses, being tested without wanting an HIV test was associated with residing 
in prison facility M1 (compared to F1), having no prior incarcerations, reporting no use of 
marijuana or crack/powder cocaine, not attending the HIV course, thinking that HIV testing 
was not mandatory, having lower HIV knowledge, and having a higher HIV cognitive 
distancing score (Table 3).
In the multivariable model, not wanting an HIV test was associated with residing at the M1 
prison facility (PR=4.78, 95% CI 1.14–20.11, compared to F1), having no prior 
incarcerations (PR=1.59, 95% CI 1.03–2.46), and having not used crack or powder cocaine 
in the three months prior to incarceration (PR=2.37, 95% CI 1.21–4.64) (Table 3).
Analysis of statistical power. Given the observational nature of the study and the fixed 
sample size(s), we estimated statistical power for contrasts within each variable in our 
bivariate analyses (e.g. power to detect a difference in the proportion of Blacks and Whites 
who thought they had not been tested for HIV). We identified contrasts with a power of 
≥80% (with a 2-sided test and alpha=0.05), as this is commonly used as a threshold for 
sufficient power. For the outcome “Thought not tested,” power was ≥ 80% for contrasts 
within the following variables: Gender, Thought testing was mandatory, Attended the HIV 
course, and Facility (contrasts between facilities M1 and M5 with F1, the referent). 
Comparisons of means for cognitive distance and HIV knowledge between those “thought 
tested” and “thought not tested” were also powered ≥ 80%. For the outcome “Did not want 
to be HIV tested,” contrasts with power ≥ 80% included facility M1 (compared to F1), 
Previous incarceration, History of Crack use, Thought testing was mandatory, and HIV 
course attendance; among continuous variables, the contrasts for cognitive distancing but not 
HIV knowledge was sufficiently powered.
DISCUSSION
HIV testing is integral to the seek-test-treat-retain model for control of the HIV epidemic. 
However, although HIV testing can afford considerable personal and public health benefit, it 
remains potentially sensitive given the stigmatization and discrimination known to occur 
among individuals identified to be infected with HIV (21), particularly in correctional 
settings. Opt-out testing policies have the potential to yield high rates of HIV testing while 
maintaining inmates’ right to refuse the test (4), although in practice, they have not always 
yielded higher rates of newly diagnosed HIV (22). The CDC’s 2006 recommendations for 
opt-out testing state that if the patient has given general consent for medical care, pre-test 
counseling and informed consent for the HIV test are not required; rather, the patient is 
notified that testing will be conducted unless the patient declines testing (11). However, 
depending on the implementation of opt-out policies, some inmates may still be at risk of 
being HIV tested against their wishes or without complete and informed awareness. The 
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current research is an exploratory and novel study of risk factors for prison inmates being 
tested without their awareness or against their wishes in an opt-out setting.
In the broader study, which enrolled a representative sample of NC prison inmates 
undergoing opt-out testing, the vast majority (95%) received an HIV test, but roughly one-
fifth of those receiving a test were unaware of having been tested and/or did not want a test 
(15). We sought in this study to examine which inmates were most vulnerable to receiving 
these two discordant testing outcomes. We found that inmates were more likely to be 
unaware that they had been tested if they resided at certain prison facilities (described 
below), had not attended the educational HIV course provided at some prison facilities, 
correctly perceived that testing was not mandatory, and had lower HIV knowledge scores. 
Those who were more likely to be tested without wanting a test resided at one specific 
prison facility, had never been incarcerated, and reported no recent pre-incarceration use of 
crack or powder cocaine.
Although inmates may refuse a test for any reason under opt-out testing, most inmates are 
tested for HIV (15, 23). The occurrence of undesired and unaware testing in our sample 
(n=166, 19%) and the high numbers of inmates incorrectly reporting that HIV testing was 
mandatory in prison (n=483, 55%) may suggest inadequate or unclear communication with 
inmates about their testing options (15). The scant past research that has examined patient 
understanding of opt-out HIV testing has found a wide range of understanding in an urban 
U.S. emergency department and in prenatal Sub-Saharan African settings (24–26). The 
current study is unique in examining potential factors associated with understanding of opt-
out HIV testing policies. In light of these findings in other settings, the misperception that 
opt-out HIV testing is mandatory could be expected to be even more common in correctional 
settings where coercion and power imbalances are inherent (3, 27, 28). Furthermore, nurses 
in correctional settings may lack the training and time to educate inmates fully about opt-out 
testing during processing.
Our results suggest that inmates were more susceptible to being tested without their 
knowledge or receiving an unwanted test if they had less experience with and knowledge 
about testing in prison. Inmates who had been previously incarcerated were less likely to 
have a discordant testing outcome, suggesting that prior incarceration experience may have 
increased their understanding of their ability to decline the test; however, considering that 
North Carolina had opt-in testing prior to November, 2008, it is not likely that the majority 
of those inmates had directly experienced opt-out testing during their prior incarcerations. 
Rather, prior incarceration may have reduced their general confusion during the intake 
processing and improved their ability to understand opt-out testing when it was presented 
during medical consent, or those incarcerated prior to November 2008 may have believed 
testing was still opt-in.
Those who did not attend the HIV course were also at higher risk of being tested without 
their awareness, possibly due to missing important information about prison testing policy 
discussed in the course. Also, those who endorsed the incorrect statement that HIV testing at 
the prison was mandatory were much more likely to be aware of receiving an HIV test, 
likely due to believing that all inmates were tested without the option of refusing.
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Environmental factors may also influence the likelihood that an inmate is unaware of being 
tested or tested against his/her wishes. Participants residing at one male prison facility (M1) 
were at highest likelihood of receiving both discordant outcomes, and those residing at two 
other male prison facilities (M2 and M5) were at increased risk of being unaware of having 
been tested. A number of facility-level characteristics, such as the practices and beliefs of 
individual staff members, staff and inmate norms and culture, and prison-specific policies 
and procedures, may explain the facility differences in undesired testing and unawareness of 
testing in our study results. For example, HIV testing is presented to women inmates as one 
of a series of reproductive health tests (including testing for pregnancy and other sexually 
transmitted infections), which may account for women’s increased awareness of being 
tested. Furthermore, availability of the educational HIV course can also affect awareness of 
being tested. At the time of this study, female prison processing facilities in North Carolina 
did not offer the course, meaning that female prisoners did not have that structured 
opportunity to learn about HIV testing policy and were more likely to perceive testing as 
mandatory (15). Curiously, although women were more likely to perceive the test as 
mandatory in our previous study (15), women were less likely than men to be tested against 
their wishes, possibly due to the higher likelihood of women to engage in health-promoting 
behaviors (29). Such differences may partially explain why the three facilities at increased 
risk for discordant outcomes were those housing male rather than female inmates.
Inmates who used crack or powder cocaine were significantly less likely to have an 
undesired HIV test. Many factors may account for this result. It is possible that inmates 
reporting crack or cocaine use are more likely to want an HIV test because they represent a 
more disadvantaged population and perceive HIV testing in prison as an important and 
accessible health care opportunity (30). Additionally, those with a history of crack and 
cocaine use may have engaged in more HIV risk behaviors and therefore felt that testing was 
more relevant for them (31). These theories are supported by the fact that in the full sample 
from our study (including both inmates who received and did not receive an HIV test), a 
significantly higher percentage of inmates who used crack or powder cocaine reported 
wanting an HIV test than among those who reported no use (94.4% vs. 87.1% respectively, 
p=0.0016).
Finally, we found that increased cognitive distancing—whereby individuals think of 
themselves as dissimilar from those with HIV (18)—was related to inmates’ low testing 
awareness and desire in the bivariate but not multivariable models. Cognitive distancing is a 
key component of stigma (18), which itself has been identified as an important limiting 
factor to uptake of opt-out testing among inmates in Baltimore jails (13) and was described 
as a barrier to seeking HIV testing among inmates in the southern U.S. (32). More research 
is needed to understand how stigma, and its components, influence prisoners’ perceived risk 
and sense of personal relevance of HIV.
This study has several limitations. Most importantly, due to the cross-sectional study design, 
the measures included in the survey instrument were not designed with the objective of 
determining causation, particularly with the complex outcomes we examined in this 
analysis. Participants may have been influenced by social desirability bias in their survey 
responses, although we believe that we minimized this effect by administering the surveys 
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via ACASI, supported by the relatively frequent reporting of traditionally stigmatized 
behavior in this sample such as risky sex and substance abuse. Additionally, our study did 
not collect data on each inmate’s communication with prison staff during medical screening, 
which would have increased our understanding of factors leading to discordance in testing 
outcome. Although our study has a large overall sample, we found that some analyses were 
under-powered. Additionally, while our sample is representative of the NC prison 
population, our findings are limited in their generalizability to other correctional systems. 
Finally, due in part to its novelty, this study was not theoretically based or guided, but rather 
conducted for exploratory purposes to understand the phenomenon of disagreements in 
testing, testing awareness, and testing desire in opt-out prison settings. In spite of these 
limitations, this study makes a worthwhile contribution in its novel exploration of discordant 
testing outcomes in opt-out prison settings.
Prison systems with opt-out policies should consider enhancing their implementation so that 
all inmates are informed and tested in accordance with their wishes. Understanding which 
groups are vulnerable to having discordant testing outcomes under opt-out policies may 
assist prisons in targeting these efforts. Our study suggests that efforts to increase awareness 
of opt-out policies are needed and are particularly important to those residing at certain male 
prison facilities, and to those who have never been previously incarcerated or did not 
recently use substances. Communication about opt-out testing may be most effective when 
paired with messages to increase inmates’ sense of personal relevance or risk for HIV. The 
educational HIV course already offered at many prison facilities decreased inmates’ 
likelihood of being tested without their awareness, and should therefore be considered an 
important opportunity for enhanced communication of prison testing policies, particularly if 
inmates attend the course prior to being offered HIV testing. Future research efforts should 
seek to more broadly assess the associations demonstrated in this research with the ultimate 
goal of improving testing outcomes for vulnerable groups in opt-out settings.
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Number of NC prison inmates receiving an HIV test without being aware and/or against 
their wishes in an opt-out HIV testing setting, 2010–2011. Note: Diagram is not 
proportional. The groups in the blue circles comprise part of the 871 who received a test. 3 
observations had missing data for the variable “wanted a test”.
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Table 1
Characteristics of study participants receiving an HIV test in the NC prison system, 2010–2011 (n=871)
%a Lower 95% CI Upper 95% CI
Race/ethnicity
 White 43.1 39.8 46.3
 Black 46.8 43.5 50.2
 Other 10.1 8.1 12.1
Age
 18–24b 23.8 21.0 26.7
 25–31 25.2 22.3 28.2
 32–40 25.7 22.8 28.6
 41–64 25.2 22.3 28.2
Gender
 Female 13.4 11.2 15.7
 Male 86.6 84.3 88.8
Sexual identity
 Men who have sex with women 85.8 83.3 88.2
 Men who have sex with men 0.9 0.2 1.6
 Men who have sex with men and women 0.6 0.1 1.2
 Women who have sex with men 11.0 11.0 13.2
 Women who have sex with women 0.4 0.0 0.8
 Women who have sex with men and womenc 1.3 0.5 2.1
Education
 <High school 37.8 34.6 41.1
 High school or GED 38.3 35.0 41.6
 >High schoolb 23.9 21.0 26.7
Prison facilityd
 F1 4.9 3.5 6.4
 F2 8.5 6.6 10.3
 M1 5.9 4.3 7.4
 M2 22.8 20.1 25.6
 M3 28.2 25.3 31.2
 M4 20.2 17.5 22.9
 M5 9.4 7.5 11.4
Previously incarceratedb 83.1 80.6 85.6
Time ever in prisone
 <1 year 55.3 51.7 59.0
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%a Lower 95% CI Upper 95% CI
 ≥1 year 44.7 41.0 48.3
Ever received an HIV test prior to incarcerationb 81.5 78.9 84.1
Binge alcohol usef
 Every day 13.0 10.7 15.2
 2–6 times per week 23.6 20.8 26.4
 <2–6 times per weekb 63.4 60.2 66.6
Substance usef
 Marijuanab 57.1 53.8 60.5
 Crack or cocaine 27.8 24.8 30.8
 Methamphetamineb 6.9 5.2 8.6
 Heroinb 6.1 4.5 7.7
Past STI diagnosis 18.7 16.1 21.3
Mental illness
 Depression 26.9 24.0 29.9
 Anxietyb 24.1 21.3 27.0
Sexual riskf
 Unprotected vaginal or anal intercourseg 71.1 67.9 74.3
 Received sex in exchange for money, drugs, food, or shelterb 7.7 5.9 9.5
 Gave sex in exchange for money, drugs, food, or shelterb 7.9 6.1 9.7
 Had multiple sexual partnersb 35.4 32.2 38.6
Thought HIV testing in the prison was mandatory 55.5 52.2 58.8
Attended the HIV course 63.8 60.6 67.0
Mean score Lower Upper
95% CI 95% CI
HIV knowledgeh 16.9 16.6 17.2
Cognitive distancingi 6.81 6.55 7.08
Support for mandatory disclosure to correctional officersj 1.77 1.69 1.85
Support for mandatory disclosure to inmatesj 2.04 1.96 2.11
a
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d









22-item HIV knowledge scale. Scores could range from 0–22, with higher scores indicating higher HIV knowledge (1).
i
5-item cognitive distancing scale. Scores could range from 0–15, with higher scores indicating higher cognitive distancing (2). 51 (5.8%) missing.
j
4-point support for mandatory disclosure scale. Scores could range from 0–3, with higher scores indicating stronger agreement.
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